First international consensus on the diagnosis and management of fibromuscular dysplasia.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
02 2019
Historique:
entrez: 15 1 2019
pubmed: 15 1 2019
medline: 31 3 2020
Statut: ppublish

Résumé

This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia (FMD) which was commissioned by the Working Group 'Hypertension and the Kidney' of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM). This document updates previous consensus documents/scientific statements on FMD published in 2014 with full harmonization of the position of European and US experts. In addition to practical consensus-based clinical recommendations, including a consensus protocol for catheter-based angiography and percutaneous angioplasty for renal FMD, the document also includes the first analysis of the European/International FMD Registry and provides updated data from the US Registry for FMD. Finally, it provides insights on ongoing research programs and proposes future research directions for understanding this multifaceted arterial disease.

Identifiants

pubmed: 30640867
doi: 10.1097/HJH.0000000000002019
pii: 00004872-201902000-00002
doi:

Types de publication

Consensus Development Conference Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

229-252

Subventions

Organisme : British Heart Foundation
ID : PG/13/96/30608
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Auteurs

Heather L Gornik (HL)

Division of Cardiovascular Medicine, Department of Cardiovascular Medicine, University Hospitals Cleveland Medical Center and UH Harrington Heart and Vascular Institute, Cleveland, Ohio, USA.

Alexandre Persu (A)

Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.

David Adlam (D)

Department of Cardiovascular Sciences.
NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.

Lucas S Aparicio (LS)

Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Michel Azizi (M)

Paris Descartes University.
Hypertension Unit, Assistance-Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou.
Institut National de la Santé et de la Recherche Médicale, Centre d'Investigation Clinique 1418, Paris.

Marion Boulanger (M)

Normandie Université, UNICAEN, Inserm U1237, CHU Caen Normandie, Caen, France.

Rosa M Bruno (RM)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Peter De Leeuw (P)

Department of Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.

Natalia Fendrikova-Mahlay (N)

Division of Cardiovascular Medicine, Department of Cardiovascular Medicine, University Hospitals Cleveland Medical Center and UH Harrington Heart and Vascular Institute, Cleveland, Ohio, USA.

James Froehlich (J)

Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Santhi K Ganesh (SK)

Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Bruce H Gray (BH)

University of South Carolina School of Medicine Greenville, Greenville, South Carolina, USA.

Cathlin Jamison (C)

Association Belge De Patients Atteints De Dysplasie Fibromusculaire/FMD Groep België (FMD-Be), Brussels, Belgium.

Andrzej Januszewicz (A)

Department of Hypertension, Institute of Cardiology, Warsaw, Poland.

Xavier Jeunemaitre (X)

APHP, Department of Genetics and Centre for Rare Vascular Diseases, Hôpital Européen Georges Pompidou.
INSERM, U970 - PARCC, University Paris Descartes, Sorbonne Paris Cité, Paris, France.

Daniella Kadian-Dodov (D)

Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York.

Esther S H Kim (ESH)

Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Jason C Kovacic (JC)

Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York.

Pamela Mace (P)

Fibromuscular Dysplasia Society of America (FMDSA), North Olmsted, Ohio, USA.

Alberto Morganti (A)

Centro Fisiologia Clinica e Ipertensione, Policlinico Hospital, University of Milan, Milan, Italy.

Aditya Sharma (A)

Cardiovascular Medicine Division, Department of Medicine.

Andrew M Southerland (AM)

Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.

Emmanuel Touzé (E)

Normandie Université, UNICAEN, Inserm U1237, CHU Caen Normandie, Caen, France.

Patricia Van der Niepen (P)

Department of Nephrology and Hypertension, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

Jiguang Wang (J)

Shanghai Institute of Hypertension and Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Ido Weinberg (I)

Vascular Medicine Section and Vascular Center, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.

Scott Wilson (S)

Monash University (Central Clinical School of Medicine).
Department of Renal Medicine, Alfred Health, Melbourne, Victoria, Australia.

Jeffrey W Olin (JW)

Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York.

Pierre-Francois Plouin (PF)

Paris Descartes University.
Hypertension Unit, Assistance-Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou.
Institut National de la Santé et de la Recherche Médicale, Centre d'Investigation Clinique 1418, Paris.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH